Special offer -15%

Vétoquinol
Cefaseptin 300 mg for dogs 100 tablets

For the treatment of bacterial skin infections and urinary-tract infections in dogs

This drug is unauthorized in certain countries
Prescription required* (Exceptions apply)

Cefaseptin 300 mg is a beige oblong tablet for:

  • The treatment of bacterial skin infections (including deep and superficial pyoderma) caused by organisms, including Staphylococcus spp., susceptible to cefalexin.
  • The treatment of urinary-tract infections (including nephritis and cystitis) caused by organisms, including Escherichia coli, susceptible to cefalexin.

One Cefaseptin 300 mg tablet contains:

Active substance:

  • cefalexin (as cefalexin monohydrate) 300 mg

Excipients:

  • Lactose monohydrate
  • Povidone K30
  • Croscarmellose sodium
  • Microcrystalline cellulose
  • Porcine liver powder
  • Yeast
  • Crospovidone
  • Sodium stearyl fumarate

Cefaseptin 300 mg:

  • Must not be use it in cases of known hypersensitivity to the active substance, to other cephalosporins, to other substances of the β-lactam group or to any of the excipients.
  • Must not be use it in the case of resistance to cephalosporins or penicillins.
  • Must not be use it in rabbits, guinea pigs, hamsters and gerbils.

Cefalexin acts by inhibiting the nucleopeptide synthesis of the bacterial wall. Cephalosporins interfere with the enzymes of transpeptidation making it unable to cross-link the peptidoglycans of the bacterial cell wall. The glycan cross-linking is essential for the cell to build its cell wall. Inhibition of the biosynthesis results to a weakened cell wall, which eventually ruptures to osmotic pressure. The combined action results in cell lysis and filament formation.

Cefalexin is active against a wide range of Gram-positive (e.g. Staphylococcus spp.) and Gram-negative (e.g. Escherichia coli) aerobic bacteria.

Cefaseptin 300 mg posology:

  • For oral administration.
  • 15 mg of cefalexin per kg of bodyweight twice daily (equivalent to 30 mg per kg of bodyweight per day) for a duration of:
    • 14 days in case of urinary-tract infection
    • at least 15 days in case of superficial bacterial infection of the skin.
    • at least 28 days in case of deep bacterial infection of the skin.

To ensure correct dosage, bodyweight should be determined as accurately as possible to avoid underdosing.

The product may be crushed or added to food if necessary.

In severe or acute conditions, except in cases of known renal insufficiency, the dose may be doubled.

Cefaseptin 300 mg is a beige oblong tablet for:

  • The treatment of bacterial skin infections (including deep and superficial pyoderma) caused by organisms, including Staphylococcus spp., susceptible to cefalexin.
  • The treatment of urinary-tract infections (including nephritis and cystitis) caused by organisms, including Escherichia coli, susceptible to cefalexin.

One Cefaseptin 300 mg tablet contains:

Active substance:

  • cefalexin (as cefalexin monohydrate) 300 mg

Excipients:

  • Lactose monohydrate
  • Povidone K30
  • Croscarmellose sodium
  • Microcrystalline cellulose
  • Porcine liver powder
  • Yeast
  • Crospovidone
  • Sodium stearyl fumarate

Cefaseptin 300 mg:

  • Must not be use it in cases of known hypersensitivity to the active substance, to other cephalosporins, to other substances of the β-lactam group or to any of the excipients.
  • Must not be use it in the case of resistance to cephalosporins or penicillins.
  • Must not be use it in rabbits, guinea pigs, hamsters and gerbils.

Cefalexin acts by inhibiting the nucleopeptide synthesis of the bacterial wall. Cephalosporins interfere with the enzymes of transpeptidation making it unable to cross-link the peptidoglycans of the bacterial cell wall. The glycan cross-linking is essential for the cell to build its cell wall. Inhibition of the biosynthesis results to a weakened cell wall, which eventually ruptures to osmotic pressure. The combined action results in cell lysis and filament formation.

Cefalexin is active against a wide range of Gram-positive (e.g. Staphylococcus spp.) and Gram-negative (e.g. Escherichia coli) aerobic bacteria.

Cefaseptin 300 mg posology:

  • For oral administration.
  • 15 mg of cefalexin per kg of bodyweight twice daily (equivalent to 30 mg per kg of bodyweight per day) for a duration of:
    • 14 days in case of urinary-tract infection
    • at least 15 days in case of superficial bacterial infection of the skin.
    • at least 28 days in case of deep bacterial infection of the skin.

To ensure correct dosage, bodyweight should be determined as accurately as possible to avoid underdosing.

The product may be crushed or added to food if necessary.

In severe or acute conditions, except in cases of known renal insufficiency, the dose may be doubled.

77.86
91.60 €
Order within 4h 54m 47s (before 12AM)
And receive your order
on Thursday 22 August
AIR FREIGHT

Customers who buy this product, usually buy: